Literature DB >> 17629178

Retrospective study of pulmonary hypertensive patients: is right ventricular myocardial performance index a vital prognostic factor?

Ioulia Grapsa1, Harry Pavlopoulos, David Dawson, J Simon R Gibbs, Petros Nihoyannopoulos.   

Abstract

INTRODUCTION: Right ventricular function is a determinant of prognosis and survival in patients with pulmonary hypertension. The pulmonary hypertensive right ventricle has a complex shape. Transthoracic two-dimensional echocardiography is the primary examination for demonstrating right ventricular impairment. Nowadays, many indices have been linked with pulmonary hypertension. The myocardial performance index (MPI), which may be determined by both conventional Doppler and tissue Doppler imaging (TDI), is one of these.
METHODS: Ninety-three patients with pulmonary hypertension were examined retrospectively over 3 years' treatment. The relationship between MPI and right ventricular impairment was studied, as well as the correlation with various echocardiographic determinants. In addition, we examined the correlation between conventional echocardiography and tissue Doppler imaging with reference to the MPI.
RESULTS: MPI had a statistically significant relationship with the visual estimation of right ventricular impairment (r = 0.714, p = 0.001), the degree of pulmonary regurgitation (r = 0.155, p = 0.048), left ventricular eccentricity index (r = 0.299, p = 0.001 in systole) and the presence of pericardial effusion (r = 0.199, p = 0.008), while it was inversely correlated with left ventricular fractional shortening (r = -0.284, p = 0.001). However, the index had no correlation with tricuspid regurgitant velocity, right ventricular acceleration time or right atrial volume. There was significant agreement between the MPI measured by conventional Doppler echocardiography and by TDI (r = 0.83, p < 0.001; mean value -0.10, SD 0.2). Finally, some patients showed a significant decrease in tricuspid regurgitant velocity and MPI during their treatment.
CONCLUSION: Right ventricular MPI has a good correlation with several parameters and can be a good prognostic factor for right ventricular impairment in patients with pulmonary hypertension.

Entities:  

Mesh:

Year:  2007        PMID: 17629178

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  6 in total

1.  Assessment of RV Function in Patients of (COPD).

Authors:  Maumita Das; Sumit Roy Tapadar; Anil Baran Singha Mahapatra; Shankar Paul Chowdhury; Subrata Basu
Journal:  J Clin Diagn Res       Date:  2014-03-15

2.  Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion.

Authors:  Feyzullah Besli; Cengiz Basar; Mesut Kecebas; Yasin Turker
Journal:  J Interv Card Electrophysiol       Date:  2015-01-16       Impact factor: 1.900

Review 3.  Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course.

Authors:  Fabiana Baldi; Leonello Fuso; Eugenio Arrighi; Salvatore Valente
Journal:  Ther Clin Risk Manag       Date:  2014-10-07       Impact factor: 2.423

4.  The Tei index and asymptomatic myocarditis in children with severe dengue.

Authors:  Dinesh Kumar Yadav; Sandeep Choudhary; Pankaj Kumar Gupta; Mukesh Kumar Beniwal; Sheetal Agarwal; Umesh Shukla; N K Dubey; Jhuma Sankar; Pradeep Kumar
Journal:  Pediatr Cardiol       Date:  2013-02-09       Impact factor: 1.838

5.  Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin.

Authors:  Majdy Idrees; Khalid Alnajashi; Jasim Abdulhameed; Atika Khan; Enas Batubara; Abdelmajeed Alotay; Amal Fayed; Saleh Aldammas; Moaad Alseif; Husam Alawwad; Yahya Abusabaa; Mashael Almobrad; Tarek Kashour
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

6.  Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.

Authors:  Majdy M Idrees; Sarfraz Saleemi; M Ali Azem; Saleh Aldammas; Manal Alhazmi; Javid Khan; Abdulgafour Gari; Maha Aldabbagh; Husam Sakkijha; Abdulla Aldalaan; Khalid Alnajashi; Waleed Alhabeeb; Imran Nizami; Amjad Kouatli; May Chehab; Omar Tamimi; Hanaa Banjar; Tarek Kashour; Antonio Lopes; Omar Minai; Paul Hassoun; Qadar Pasha; Eckhard Mayer; Ghazwan Butrous; Sastry Bhagavathula; Stefano Ghio; John Swiston; Adel Boueiz; Adriano Tonelli; Robert D Levy; Marius Hoeper; Rober D Levy
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.